Doctor of Philosophy Program in Social, Economic and Administrative Pharmacy, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
Faculty of Medical Sciences, Aljanad University for Science and Technology, Taiz, Yemen.
Glob Health Res Policy. 2022 Jul 25;7(1):25. doi: 10.1186/s41256-022-00258-y.
Economic evaluation studies demonstrate the value of money in health interventions and enhance the efficiency of the healthcare system. Therefore, this study reviews published economic evaluation studies of public health interventions from 26 Middle East and North Africa (MENA) countries and examines whether they addressed the region's major health problems.
PubMed and Scopus were utilized to search for relevant articles published up to June 26, 2021. The reviewers independently selected studies, extracted data, and assessed the quality of studies using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist.
The search identified 61 studies. Approximately half (28 studies; 46%) were conducted in Israel and Iran. The main areas of interest for economic evaluation studies were infectious diseases (21 studies; 34%), cancers (13 studies; 21%), and genetic disorders (nine studies; 15%). Five (8%), 39 (64%), 16 (26%), and one (2%) studies were classified as excellent, high, average, and poor quality, respectively. The mean of CHEERS checklist items reported was 80.8% (SD 14%). Reporting the structure and justification of the selected model was missed in 21 studies (37%), while price and conversion rates and the analytical methods were missed in 21 studies (34%).
The quantity of economic evaluation studies on public health interventions in the MENA region remains low; however, the overall quality is high to excellent. There were obvious geographic gaps across countries regarding the number and quality of studies and gaps within countries concerning disease prioritization. The observed research output, however, did not reflect current and upcoming disease burden and risk factors trends in the MENA region.
经济评估研究表明了卫生干预措施中资金的价值，并提高了医疗保健系统的效率。因此，本研究回顾了来自 26 个中东和北非（MENA）国家的公共卫生干预措施的已发表经济评估研究，并考察了这些研究是否解决了该地区的主要卫生问题。
使用 PubMed 和 Scopus 检索截至 2021 年 6 月 26 日发表的相关文章。审查员独立选择研究，提取数据，并使用统一健康经济评估报告标准（CHEERS）清单评估研究质量。
搜索确定了 61 项研究。大约一半（28 项；46%）的研究在以色列和伊朗进行。经济评估研究的主要关注领域是传染病（21 项；34%）、癌症（13 项；21%）和遗传疾病（9 项；15%）。5 项（8%）、39 项（64%）、16 项（26%）和 1 项（2%）研究的质量分别被归类为优秀、高、中、低。报告的 CHEERS 清单项目平均值为 80.8%（SD 14%）。21 项研究（37%）遗漏了模型的结构和依据，21 项研究（34%）遗漏了价格和换算率以及分析方法。
MENA 地区公共卫生干预措施的经济评估研究数量仍然较少，但总体质量较高，为优秀。各国在研究数量和质量方面存在明显的地域差距，在疾病优先排序方面，各国国内也存在差距。然而，观察到的研究成果并没有反映出 MENA 地区当前和即将出现的疾病负担和风险因素趋势。
